Immunisation coverage among babies under eight months

Graph denotes the number of infants who have received nirsevimab (Beyfortus) before eight months. This does not include those covered by the maternal RSV vaccine.

Reporting of RSV monoclonal antibodies to the AIR is not compulsory, meaning coverage estimates are likely to be underestimated.
Source: Australian Immunisation Register (AIR)